Successful treatment of psoriatic arthritis and comorbid annular atrophic lichen planus with etanercept.
inflammation
lichen planus
psoriasis
psoriatic arthritis
tumor necrosis factor-α
Journal
The Journal of dermatology
ISSN: 1346-8138
Titre abrégé: J Dermatol
Pays: England
ID NLM: 7600545
Informations de publication
Date de publication:
Apr 2020
Apr 2020
Historique:
received:
26
03
2019
accepted:
12
12
2019
pubmed:
8
1
2020
medline:
7
1
2021
entrez:
8
1
2020
Statut:
ppublish
Résumé
Psoriasis vulgaris and lichen planus are distinct T-cell-driven inflammatory skin diseases. Both present in a variety of clinical subtypes. Mucosal or nail involvement may be present. Here, we report the rare concomitant clinical presentation of psoriatic arthritis and annular atrophic lichen planus on the trunk of a 52-year-old male patient. Treatment with sulfasalazine failed to control inflammatory activity; methotrexate and leflunomide were ceased due to side-effects. After confirmation of both diagnoses, we initiated a tumor necrosis factor (TNF)-α-directed therapy with the fusion protein etanercept resulting in significant improvement of both conditions. This case report aims to highlight the rare colocalization of psoriasis and lichen planus, the rare entity of annular atrophic lichen planus, and to discuss a possible beneficial impact of certain TNF-α inhibitors on subtypes of lichen planus.
Identifiants
pubmed: 31907939
doi: 10.1111/1346-8138.15222
doi:
Substances chimiques
Immunosuppressive Agents
0
TNF protein, human
0
Tumor Necrosis Factor-alpha
0
Etanercept
OP401G7OJC
Types de publication
Case Reports
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
397-401Informations de copyright
© 2020 The Authors. The Journal of Dermatology published by John Wiley & Sons Australia, Ltd on behalf of Japanese Dermatological Association.
Références
Weston G, Payette M. Update on lichen planus and its clinical variants. Int J Womens Dermatol 2015; 1(3): 140-149.
Friedman DB, Hashimoto K. Annular atrophic lichen planus. J Am Acad Dermatol 1991; 25(2 Pt 2): 392-394.
Tamer F, Orenay OM, Sarifakioglu E, Bayrak R. Annular atrophic lichen planus: A rare clinical entity. J Dtsch Dermatol Ges 2017; 15(8): 831-832.
Asarch A, Gottlieb AB, Lee J, et al. Lichen planus-like eruptions: An emerging side effect of tumor necrosis factor-alpha antagonists. J Am Acad Dermatol 2009; 61(1): 104-111.
Chao TJ. Adalimumab in the management of cutaneous and oral lichen planus. Cutis 2009; 84(6): 325-328.
Irla N, Schneiter T, Haneke E, Yawalkar N. Nail lichen planus: successful treatment with etanercept. Case Rep Dermatol 2010; 2(3): 173-176.
Yamanaka Y, Akiyama M, Shibaki A, Kikuchi T, Shimizu H. Annular lichen planus: study of the cellular mechanisms of annularity. Dermatology (Basel) 2004; 208(4): 335-338.
Ohta Y, Yonemoto K, Asai T, Yaguchi A. Lichen planus annularis: an immunohistochemical study. J Dermatol 1992; 19(7): 414-419.
Thongprasom K, Dhanuthai K, Sarideechaigul W, Chaiyarit P, Chaimusig M. Expression of TNF-alpha in oral lichen planus treated with fluocinolone acetonide 0.1%. J Oral Pathol Med 2006; 35(3): 161-166.
Saliu O, Sofer C, Stein D, Schwander S, Wallis R. Tumor-necrosis-factor blockers: differential effects on mycobacterial immunity. J Infect Dis 2006; 194: 486-492.
Piccinni M-P, Lombardelli L, Logiodice F et al. Potential pathogenetic role of Th17, Th0, and Th2 cells in erosive and reticular oral lichen planus. Oral Dis 2014; 20(2): 212-218.
Raychaudhuri SP. A cutting edge overview: psoriatic disease. Clin Rev Allergy Immunol 2013; 44(2): 109-113.
Ohshima N, Shirai A, Asahina A. Coexistence of linear lichen planus and psoriasis in a single patient. J Dermatol 2011; 38(12): 1182-1184.
Shiohara T, Hayakawa J, Nagashima M. Psoriasis and lichen planus: coexistence in a single patient. Are both diseases mutually exclusive? Dermatologica 1989; 179(4): 178-182.
Sticherling M. Psoriasis and autoimmunity. Autoimmun Rev 2016; 15(12): 1167-1170.